Fresenius Medical Care AG (FMEd)

CBOE (Germany)Healthcare

€36.65
+€0.67 (+1.9%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
FMEd
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Fresenius Medical Care AG

Name

Fresenius Medical Care AG

CEO

Helen Giza

Industry

Healthcare

Employees

112,035

Fresenius Medical Care AG delivers kidney-care services and therapy systems used in routine clinical practice. The company runs treatment networks and manufactures equipment under one quality framework designed for repeatable care. Its model pairs clinic operations with product supply, so planning for capacity and logistics sits alongside validation and field support. Activity is global and concentrated in regulated healthcare systems. Over time the business expanded its installed base and clinic footprint while standardizing documentation, training, and service procedures. Clinical software supports scheduling and outcome tracking, and governance keeps patient safety and data integrity central to decisions. Within the healthcare sector, the company occupies the link between care delivery and the industries that supply and fund it, operating as a platform that moves patients from initiation to ongoing monitoring without breaking the record of care.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 4 Buy, 3 Hold, 17 Sell
Buy4
Hold3
Sell17
Fundamentals & Financials
Revenue (TTM)
€19.6B
Net Income (TTM)
€718.2M
EPS (TTM)
€2.46
ROA (TTM)
2.33%
Current Ratio
1.36
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue€4,884.8M
Cost of Sales€3,642.6M
Gross Profit€1,242.2M
Operating Income€476,505K
Net Income€274,797K
EPS€0.94
Technical Indicators

Fresenius Medical Care AG's Technical Indicators Summary

FMEd is displaying a bearish trend with price currently below all major moving averages, including the 200-day, which signals sustained downward pressure. Momentum indicators present a mixed picture: the RSI and Stochastic suggest oversold conditions and a possible buy signal, yet the MACD and CCI continue to confirm selling momentum. The ADX indicates a moderate trend strength, neither strongly directional nor weak. Volatility remains steady with the ATR holding firm, while volume trends as reflected by OBV point to continued selling interest. Additionally, the price trading below both the VWAP and classic pivot levels reinforces resistance overhead. Overall, FMEd’s technical profile remains bearish amid some short-term oversold signals.

Buy
4 signals
Neutral
3 signals
Sell
17 signals
Overall: Bearish71% Bearish signals
IndicatorValue
RSI (14)
28.36
Stochastic %K (14, 3, 3)
15.64
CCI (20)
-171.92
WPR (14)
-97.49
Momentum (10)
-4.29
MFI
25.41
MACD Level (12, 26)
-1.03
Bollinger Bands
$36.20 - $42.47
ATR (14)
$0.92 (2.55%)
ADX (14)
24.38
OBV
3,241,265
VWAP
$36.10
Classic Pivot Point
$37.14
Fibonacci Pivot Point
$37.14
Exponential Moving Averages
$37.93 - $43.48(5 indicators)
Simple Moving Averages
$38.21 - $44.42(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

A modest upside read shows FME.DE 1.001% above yesterday’s close at 36.34. No strong read from the sector, which sits near flat at -0.22%. FME.DE edges higher amid limited sector movement with no recent company-specific news driving the change.

Price Change

from €35.98 close

+€0.36

Trading Volume

Below avg (1.2M)

227.4K

vs S&P 500 Today

Outperforming Market

+2.42%

52-Week Position

Near lows

3.7%

Updated: January 21, 2026 at 12:37 UTC

Quote Summary
OpenPrevious Close
€36.16€35.98
Day Range52 Week Range
€36.16 - €37.02€35.67 - €54.02
VolumeAvg. Volume
887.4K749.5K
Market CapP/E Ratio
€10.7B15.0